Form 4: Sarepta EVP's Tax Withholding on Stock Vesting
Insider Transaction Report
Sarepta Therapeutics' EVP and General Counsel, Cristin Rothfuss, reported a disposition of 229 common shares for tax withholding purposes related to restricted stock unit vesting.
Summary
- Cristin Rothfuss, Executive Vice President and General Counsel of Sarepta Therapeutics, Inc. (SRPT), reported a transaction on November 28, 2025.
- The transaction involved the disposition of 229 shares of common stock at a price of $21.12 per share.
- These shares were withheld by Sarepta Therapeutics to satisfy tax withholding obligations related to the vesting of restricted stock units that were granted on November 26, 2024.
- Following this transaction, Ms. Rothfuss directly beneficially owns 139,756 shares of Sarepta Therapeutics common stock.
Sentiment
Score: 5
Explanation: The transaction is a routine administrative event (tax withholding) related to executive compensation and has a neutral impact on the company's fundamentals or market sentiment.
Future Outlook
NA
Industry Context
This is a routine insider transaction related to executive compensation and tax obligations, which is a common occurrence across all industries for executives receiving equity-based compensation. It does not provide insights into broader industry trends or competitive dynamics.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes related to executive compensation.
- No direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/26/2024 | Date restricted stock units were granted to Cristin Rothfuss. |
| 11/28/2025 | Date of the transaction where shares were withheld for tax obligations related to RSU vesting. |
| 12/02/2025 | Date the Form 4 was signed by Cristin Rothfuss. |
Keywords
Sarepta Therapeutics, SRPT, Form 4, Insider Transaction, Stock Vesting, Tax Withholding, Cristin Rothfuss, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.